Allergy Therapeutics plc
AGYTF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $295,093 | $177,555 | $200,679 | $309,739 |
| - Cash | $17,558 | $12,715 | $14,645 | $20,515 |
| + Debt | $60,089 | $30,988 | $35,989 | $10,529 |
| Enterprise Value | $337,624 | $195,828 | $222,023 | $299,753 |
| Revenue | $75,564 | $55,199 | $59,587 | $72,768 |
| % Growth | 36.9% | -7.4% | -18.1% | – |
| Gross Profit | $34,498 | $29,737 | $33,245 | $49,506 |
| % Margin | 45.7% | 53.9% | 55.8% | 68% |
| EBITDA | -$40,400 | -$30,740 | -$35,101 | -$7,822 |
| % Margin | -53.5% | -55.7% | -58.9% | -10.7% |
| Net Income | -$55,093 | -$40,216 | -$43,071 | -$13,776 |
| % Margin | -72.9% | -72.9% | -72.3% | -18.9% |
| EPS Diluted | -0.008 | -0.011 | -0.038 | -0.012 |
| % Growth | 21.5% | 71.5% | -213.3% | – |
| Operating Cash Flow | -$39,423 | -$32,138 | -$28,881 | -$14,372 |
| Capital Expenditures | -$4,481 | -$3,401 | -$4,669 | -$3,276 |
| Free Cash Flow | -$43,904 | -$35,539 | -$33,550 | -$17,648 |